HIF-1α mRNA was significantly expressed, similarly to VEGF, which is highly expressed in APL patients (Gutierrez et al, 2005), while HIF-2α levels were very low (Fig 3A). The gene discussed is HIF1A; the disease is acute promyelocytic leukemia.